Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2025-03-18 Sale | 2025-03-20 4:36 pm | Candel Therapeutics Inc. | CADL | Nichols William Garrett Chief Medical Officer | 45,316 | $8.7606 | $396,995 | 279,004 (Direct) | View |
| 2025-03-18 Sale | 2025-03-20 4:36 pm | Candel Therapeutics Inc. | CADL | Barone Francesca Chief Scientific Officer | 32,146 | $8.7623 | $281,673 | 127,349 (Direct) | View |
| 2025-03-18 Sale | 2025-03-20 4:35 pm | Candel Therapeutics Inc. | CADL | Tak Paul Peter Chief Executive Officer | 26,172 | $8.7737 | $229,624 | 225,740 (Direct) | View |
| 2025-03-17 Sale(A) | 2025-03-20 4:35 pm | Candel Therapeutics Inc. | CADL | Tyagarajan Seshu Chief Technology Officer | 31,278 | $8.8224 | $275,947 | 155,512 (Direct) | View |
| 2025-03-17 Sale | 2025-03-19 4:12 pm | Candel Therapeutics Inc. | CADL | Tyagarajan Seshu Chief Technology Officer | 31,278 | $8.8224 | $275,947 | 155,512 (Direct) | View |
| 2025-03-17 Sale | 2025-03-19 4:06 pm | Candel Therapeutics Inc. | CADL | Schoch Charles See Remarks | 5,000 | $8.8338 | $44,169 | 38,038 (Direct) | View |
| 2025-01-15 Sale | 2025-01-17 4:30 pm | Candel Therapeutics Inc. | CADL | Barone Francesca Chief Scientific Officer | 13,534 | $7.225 | $97,783 | 110,673 (Direct) | View |
| 2025-01-15 Sale | 2025-01-17 4:30 pm | Candel Therapeutics Inc. | CADL | Tyagarajan Seshu Chief Technology Officer | 14,322 | $7.225 | $103,476 | 96,790 (Direct) | View |
| 2025-01-15 Sale | 2025-01-17 4:30 pm | Candel Therapeutics Inc. | CADL | Schoch Charles See Remarks | 9,511 | $7.225 | $68,717 | 43,038 (Direct) | View |
| 2025-01-15 Sale | 2025-01-17 4:30 pm | Candel Therapeutics Inc. | CADL | Tak Paul Peter Chief Executive Officer | 21,704 | $7.225 | $156,811 | 251,912 (Direct) | View |
| 2025-01-15 Sale | 2025-01-17 4:30 pm | Candel Therapeutics Inc. | CADL | Nichols William Garrett Chief Medical Officer | 10,428 | $7.225 | $75,342 | 79,320 (Direct) | View |
| 2025-01-08 Sale | 2025-01-10 4:30 pm | Candel Therapeutics Inc. | CADL | Barone Francesca Chief Scientific Officer | 13,673 | $8.2182 | $112,367 | 124,207 (Direct) | View |
| 2025-01-08 Sale | 2025-01-10 4:30 pm | Candel Therapeutics Inc. | CADL | Schoch Charles See Remarks | 9,971 | $8.2182 | $81,944 | 52,549 (Direct) | View |
| 2025-01-08 Sale | 2025-01-10 4:30 pm | Candel Therapeutics Inc. | CADL | Tak Paul Peter Chief Executive Officer | 21,172 | $8.2182 | $173,996 | 273,616 (Direct) | View |
| 2025-01-08 Sale | 2025-01-10 4:30 pm | Candel Therapeutics Inc. | CADL | Tyagarajan Seshu Chief Technology Officer | 14,545 | $8.2182 | $119,534 | 111,112 (Direct) | View |
| 2025-01-08 Sale | 2025-01-10 4:30 pm | Candel Therapeutics Inc. | CADL | Nichols William Garrett Chief Medical Officer | 10,799 | $8.2183 | $88,749 | 89,748 (Direct) | View |
| 2024-12-16 Purchase | 2024-12-18 4:11 pm | Candel Therapeutics Inc. | CADL | Manning Paul B Director | 1,250,000 | $6 | $7,500,000 | 2,984,752 (Indirect Direct) | View |
| 2024-11-29 Sale | 2024-12-03 5:48 pm | Candel Therapeutics Inc. | CADL | Tyagarajan Seshu Chief Technology Officer | 20,392 | $4.5556 | $92,898 | 125,657 (Direct) | View |
| 2024-11-29 Sale | 2024-12-03 5:48 pm | Candel Therapeutics Inc. | CADL | Tak Paul Peter Chief Executive Officer | 48,847 | $4.5556 | $222,527 | 294,788 (Direct) | View |
| 2024-11-29 Sale | 2024-12-03 5:47 pm | Candel Therapeutics Inc. | CADL | Nichols William Garrett Chief Medical Officer | 13,935 | $4.5556 | $63,482 | 100,547 (Direct) | View |
| 2024-11-29 Sale | 2024-12-03 5:46 pm | Candel Therapeutics Inc. | CADL | Barone Francesca Chief Scientific Officer | 22,081 | $4.5556 | $100,592 | 137,880 (Direct) | View |
| 2024-07-17 Sale | 2024-07-19 08:31 am | Candel Therapeutics Inc. | CADL | Tyagarajan Seshu Chief Technology Officer | 14,851 | $6.4726 | $96,125 | 146,049 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2025-03-18 Exercise | 2025-03-20 4:36 pm | N/A 2032-09-12 | Candel Therapeutics Inc. | CADL | Nichols William Garrett Chief Medical Officer | 18,489 | $0 | 279,004 (Direct) | View |
| 2025-03-18 Exercise | 2025-03-20 4:36 pm | N/A N/A | Candel Therapeutics Inc. | CADL | Nichols William Garrett Chief Medical Officer | 13,905 | $1.29 | 279,004 (Direct) | View |
| 2025-03-18 Exercise | 2025-03-20 4:36 pm | N/A N/A | Candel Therapeutics Inc. | CADL | Nichols William Garrett Chief Medical Officer | 4,584 | $3.75 | 279,004 (Direct) | View |
| 2025-03-18 Exercise | 2025-03-20 4:36 pm | N/A N/A | Candel Therapeutics Inc. | CADL | Barone Francesca Chief Scientific Officer | 18,000 | $1.55 | 127,349 (Direct) | View |
| 2025-03-18 Exercise | 2025-03-20 4:36 pm | N/A 2030-12-30 | Candel Therapeutics Inc. | CADL | Barone Francesca Chief Scientific Officer | 18,000 | $0 | 127,349 (Direct) | View |
| 2025-03-17 Exercise(A) | 2025-03-20 4:35 pm | N/A 2033-04-28 | Candel Therapeutics Inc. | CADL | Tyagarajan Seshu Chief Technology Officer | 20,000 | $0 | 155,512 (Direct) | View |
| 2025-03-17 Exercise(A) | 2025-03-20 4:35 pm | N/A N/A | Candel Therapeutics Inc. | CADL | Tyagarajan Seshu Chief Technology Officer | 20,000 | $1.29 | 155,512 (Direct) | View |
| 2025-03-17 Exercise | 2025-03-19 4:12 pm | N/A 2033-04-28 | Candel Therapeutics Inc. | CADL | Tyagarajan Seshu Chief Technology Officer | 20,000 | $0 | 155,512 (Direct) | View |
| 2025-02-12 Option Award | 2025-02-14 4:30 pm | N/A 2035-02-12 | Candel Therapeutics Inc. | CADL | Schoch Charles See Remarks | 83,000 | $0 | 83,000 (Direct) | View |
| 2025-02-12 Option Award | 2025-02-14 4:30 pm | N/A 2035-02-12 | Candel Therapeutics Inc. | CADL | Nichols William Garrett Chief Medical Officer | 107,250 | $0 | 107,250 (Direct) | View |
| 2025-02-12 Option Award | 2025-02-14 4:30 pm | N/A 2035-02-12 | Candel Therapeutics Inc. | CADL | Tyagarajan Seshu Chief Technology Officer | 65,000 | $0 | 65,000 (Direct) | View |
| 2025-02-12 Option Award | 2025-02-14 4:30 pm | N/A 2035-02-12 | Candel Therapeutics Inc. | CADL | Tak Paul Peter Chief Executive Officer | 525,000 | $0 | 525,000 (Direct) | View |
| 2025-02-12 Option Award | 2025-02-14 4:30 pm | N/A 2035-02-12 | Candel Therapeutics Inc. | CADL | Barone Francesca Chief Scientific Officer | 115,000 | $0 | 115,000 (Direct) | View |
| 2024-11-21 Exercise | 2024-11-21 3:07 pm | N/A N/A | Candel Therapeutics Inc. | CADL | Tak Paul Peter Chief Executive Officer | 12,900 | $1.55 | 2,107,603 (Direct) | View |
| 2024-11-21 Exercise | 2024-11-21 3:07 pm | N/A 2030-10-10 | Candel Therapeutics Inc. | CADL | Tak Paul Peter Chief Executive Officer | 12,900 | $0 | 2,107,603 (Direct) | View |